Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited

QR Code

Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited

Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 and CB2, and are divided into endocannabinoids, the endogenous ligands of these receptors, synthetic cannabinoids and phytocannabinoids. The latter are derived from the plant Cannabis sativa. The therap...

Full description

Bibliographic Details
Main Authors:	Constantinescu, Cris S., Gershkovich, Pavel
Format:	Article
Published:	Wiley 2018
Online Access:	https://eprints.nottingham.ac.uk/51035/

Similar Items

Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation
by: Zgair, Atheer, et al.
Published: (2017)

The future of multiple sclerosis treatments
by: Coclitu, Catalina, et al.
Published: (2016)

Role of oral teriflunomide in the management of multiple sclerosis
by: Tanasescu, Radu, et al.
Published: (2013)

Smoking cessation and the reduction of disability progression in Multiple Sclerosis: a cohort study
by: Tanasescu, Radu, et al.
Published: (2018)

Pediatric multiple sclerosis: update on diagnostic criteria, imaging, histopathology and treatment choices
by: Chou, I-Jun, et al.
Published: (2016)

Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis
by: Tanasescu, Radu, et al.
Published: (2016)

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
by: Manouchehrinia, Ali, et al.
Published: (2013)

Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis
by: Shi, Y., et al.
Published: (2017)

Functionally relevant white matter degradation in multiple sclerosis: a tract-based spatial meta-analysis
by: Welton, Thomas, et al.
Published: (2015)

Delivery of cannabinoids to specific anatomical regions of the brain following oral administration to reach the site of action for glioblastoma multiforme and multiple sclerosis
by: Brookes, Alice
Published: (2023)

The association between human endogenous retroviruses and multiple sclerosis: a systematic review and meta-analysis
by: Morandi, Elena, et al.
Published: (2017)

Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis
by: Manouchehrinia, Ali, et al.
Published: (2017)

Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis
by: Traboulsee, Anthony L., et al.
Published: (2016)

Seven-Tesla magnetization transfer imaging to detect multiple sclerosis white matter lesions
by: Chou, I-Jun, et al.
Published: (2017)

Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids
by: Brook, E., et al.
Published: (2019)

Obesity, dieting, and multiple sclerosis
by: Russell, Rebecca, et al.
Published: (2020)

circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis
by: D'Aversa, Elisabetta, et al.
Published: (2024)

Cognitive rehabilitation for attention and memory in people with multiple sclerosis: study protocol for a randomised controlled trial (CRAMMS)
by: Lincoln, Nadina, et al.
Published: (2015)

Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS)
by: Lincoln, Nadina B., et al.
Published: (2015)

Memory rehabilitation for people with multiple sclerosis
by: das Nair, Roshan, et al.
Published: (2016)

Cognitive impairment in stroke and multiple sclerosis
by: Belcher, Andrew
Published: (2021)

Brain imaging biomarkers in Multiple Sclerosis
by: Altokhis, Amjad
Published: (2023)

Multiple Sclerosis: A Disease of Affluence?
by: Buchter, B., et al.
Published: (2012)

Immunomodulation of reproductive function in domestic ruminants
by: Williams, Richard David
Published: (2004)

Deep grey matter and fatigue in multiple sclerosis
by: Niepel, Graham
Published: (2012)

Assessment of mood measures for people with multiple sclerosis
by: Hopkins, Tessa Marie
Published: (2011)

Preventing job loss for people with Multiple Sclerosis
by: De Dios Perez, Blanca
Published: (2022)

A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field
by: Cronin, Matthew John, et al.
Published: (2016)

Mesenchymal stem cell-mediated immunomodulation of microglia
by: Jose, Shinsmon
Published: (2013)

Spinal cord grey matter pathology in multiple sclerosis
by: Gilmore, Christopher Patrick
Published: (2008)

Quality of life in informal carers of individuals with multiple sclerosis
by: Topcu, Gogem
Published: (2016)

Imaging markers of brain network disruption in multiple sclerosis
by: Welton, Thomas
Published: (2017)

Multiple Sclerosis Biomarkers – moving towards clinical applications
by: Clarke, Margareta Anna
Published: (2019)

The relation of familial longevity and progression of disability in multiple sclerosis
by: Gao, Xin
Published: (2019)

The impact of the COVID-19 Pandemic on people with Multiple sclerosis
by: Garjani, Afagh
Published: (2024)

The effects of cannabinoids on insulin secretion
by: Anderson, Richard L.
Published: (2011)

Immunomodulation with self-crosslinked polyelectrolyte multilayer-based coatings
by: Knopf-Marques, Helena, et al.
Published: (2016)

Tobacco smoking and multiple sclerosis: effects on occurrence, progression and mortality
by: Manouchehrinia, Ali
Published: (2014)

Evaluation of Neurotext as a memory aid for people with multiple sclerosis
by: Goodwin, Rachel Ann
Published: (2016)

MRI white matter lesion central veins in multiple sclerosis
by: Samaraweera, Amal Prasanna Rohan
Published: (2017)